Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

International News

Merck & Co. Says European Regulators Recommend Approval of HIV Drug Isentress

November 19, 2007

European regulators have recommended approval of Merck & Co.'s HIV drug Isentress in combination with other antiretroviral (ARV) treatments, the drug maker announced on Thursday. Isentress is designed to treat HIV in adult patient who have already been receiving ARVs. The recommendation by the Committee for Medicinal Products for Human Use of the European Medicines Agency will be taken into account by the European Commission, which makes the final decision on whether to approve the drug for use in the European Union.

Back to other news for November 2007

Adapted from:
Associated Press
11.15.2007


  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
More HIV News

Tools
 

Advertisement